EMA consults on pharmacovigilance inspections, criteria for additional monitoring of drugs

The European Medicines Agency is seeking feedback on two new modules of the good pharmacovigilance practice (GVP) guideline¹. The modules explain the requirements for pharmacovigilance inspections² and the need for additional monitoring of certain drugs in the post-authorisation phase³…